Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis

Genes and Immunity

Volumn 6, Issue 5, 2005, Pages 407-415

  Kõks, Sulev ^a   Kingo, K ^a   Vabrit, K ^a   Ratsep R ^a   Karelson, M ^a   Silm, H ^a   Vasar, E ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Association; Haplotype analysis; Interleukin 24; P aque type psoriasis; Single nucleotide polymorphism (SNP)

Indexed keywords

INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 24;

ADULT; AGED; ARTICLE; CHROMOSOME 1; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS VULGARIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; INTERLEUKINS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS;

EID: 30744458384     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364216     Document Type: Article

References (59)

1. Glickman FS. Lepra, psora, psoriasis. J Am Acad Dermatol 1986; 14: 863-866.
2. Camp RDR. Psoriasis. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds). Textbook of Dermatology. Blackwell Science: Oxford, 1992, pp 1589-1649.
3. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-320.
4. Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6: 813-820.
5. Nair RP, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997; 6: 1349-1356.
6. Balendran N, Clough RL, Arguello JR et al. Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 1999; 113: 322-328.
7. Oka A, Tamiya G, Tomizawa M et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet 1999; 8: 2165-2170.
8. Veal CD, Capon F, Allen MH et al. Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am J Hum Genet 2002; 71: 554-564.
9. Asumalahti K, Veal C, Laitinen T et al. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum Mol Genet 2002; 11: 589-597.
10. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001; 2: 802-809.
11. Zhou X, Krueger JG, Kao MC et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63 100-element oligonucleotide array. Physiol Genom 2003; 13: 69-78.
12. Kim JM, Brannan CI, Copeland NG et al. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148: 3618-3623.
13. Blumberg H, Conklin D, Xu WF et al. Interleukin 20: Discovery, receptor identification, and role in epidermal function. Cell 2001; 104: 9-19.
14. Gallagher G, Dickensheets H, Eskdale J et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1: 442-450.
15. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11: 2477-2486.
16. Crawley E, Kay R, Sillibourne J et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthitis. Arthritis Rheum 1999; 42: 1101-1108.
17. Tagore A, Gonsalkorale WM, Pravica V et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386-390.
18. Gibson AW, Edberg JC, Wu J et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915-3922.
19. Shin HD, Winkler C, Stephens JC et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000; 97: 14467-14472.
20. Kingo K, Kõks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003; 4: 455-457.
21. Hensen P, Asadullah K, Windemuth C et al. Interleukin-10 promoter polymorphism IL10. G and familial early onset psoriasis. Br J Dermatol 2003; 149: 381-385.
22. Gallagher G, Eskdale J, Jordan W et al. Human interleukin-19 and its receptor: A potential role in the induction of Th2 responses. Int Immunopharmacol 2004; 4: 615-626.
23. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001; 167: 3545-3549.
24. Parrish-Novak J, Xu W, Brender T et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002; 277: 47517-47523.
25. Romer J, Hasselager E, Norby PL et al. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 2003; 121: 1306-1311.
26. Kotenko SV. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 2002; 13: 223-240.
27. Soo C, Shaw WW, Freymiller E et al. Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. J Cell Biochem 1999; 74: 1-10.
28. Ortonne JP. Aetiology and pathogenesis of psoriasis. Br J Dermatol 1996; 135 (Suppl 49): 1-5.
29. Piepkorn M, Pittelkow MR, Cook PW. Autocrine regulation of keratinocytes: The emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 1998; 111: 715-721.
30. Kõks S, Kingo K, Ratsep R et al. Combined haplotype analysis of the interleukin-19 and -20 genes: Relationship to plaque-type psoriasis. Genes Immun 2004; 5: 662-667.
31. Kingo K, Kõks S, Nikopensius T, Silm H, Vasar E. Polymorphisms in the interleukin-20 gene: Relationships to plaque-type psoriasis. Genes Immun 2004; 5: 117-121.
32. Capon F, Novelli G, Semprini S et al. Searching for psoriasis susceptibility genes in Italy: Genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999; 112: 32-35.
33. Capon F, Semprini S, Chimenti S et al. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol 2001; 116: 728-730.
34. Fickenscher H, Hor S, Kupers H et al. The interleukin-10 family of cytokines. Trends Immunol 2002; 23: 89-96.
35. Ghoreschi K, Mrowietz U, Rocken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med 2003; 81: 471-480.
36. Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: Immune cells as sources and targets of the IL-10 family members? J Immunol 2002; 168: 5397-5402.
37. Caudell EG, Mumm JB, Poindexter N et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 2002; 168: 6041-6046.
38. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 2002; 3: 391-397.
39. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004; 429: 446-452.
40. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004; 5: 89-100.
41. Cardon LR, Abecasis GR. Using haplotype blocks to map human complex trait loci. Trends Genet 2003; 19: 135-140.
42. Kauppi L, Jeffreys AJ, Keeney S. Where the crossovers are: Recombination distributions in mammals. Nat Rev Genet 2004; 5: 413-424.
43. Hafler DA, Jager PL. Opinion: Applying a new generation of genetic maps to understand human inflammatory disease. Nat Rev Immunol 2005; 5: 83-91.
44. Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870.
45. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med 2005; 56: 303-320.
46. Smith AJ, Keen LJ, Billingham MJ et al. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: Association with knee osteoarthritis. Genes Immun 2004; 5: 451-460.
47. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001; 17: 93-100.
48. Gibson F, Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004; 53: 2977-2983.
49. Laivoranta-Nyman S, Mottonen T, Hermann R et al. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1406-1412.
50. Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004; 5: 609-614.
51. Contu L, Orru S, Carcassi C et al. A psoriasis vulgaris protective gene maps close to the HLA-C locus on the EH18.2-extended haplotype. Tissue Antigens 2004; 64: 43-57.
52. Choonhakarn C, Romphruk A, Puapairoj C et al. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int J Dermatol 2002; 41: 330-334.
53. Kim TG, Lee HJ, Youn JI, Kim TY, Han H. The association of psoriasis with human leukocyte antigens in Korean population and the influence of age of onset and sex. J Invest Dermatol 2000; 114: 309-313.
54. Hensen P, Windemuth C, Huffmeier U et al. Association scan of the novel psoriasis susceptibility region on chromosome 19: Evidence for both susceptible and protective loci. Exp Dermatol 2003; 12: 490-496.
55. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456.
56. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
57. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-8.
58. Raymond M, Rousset F. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism. J Hered 1995; 86: 284-295.
59. Tregouet DA, Barbaux S, Escolano S et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002; 11: 2015-2023.